SBWire

HUDSON, MA (Feb. 21, 2023) – Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets is proud to announce that it has recently achieved ISO 14001:2015 certification for its environmental management system at their Hudson, MA facility. Bill Ellerkamp, president of Precision Coating, commented that "this certification reflects a lot of hard work by our employees and a tremendous commitment to sustainability. Having a robust and certified environmental management system in place supports and reinforces our conviction to implement best practices to meet or exceed the expectations of all of our stakeholders. This milestone marks the completion of one stage of a long journey on which we will continue to do the right thing always and be relentless about improvement."

South Shore Based Digital Media Publisher Partners with Nation’s Largest Public Ice Rink Operator 

Global Market Direct's pharmaceuticals report, "Celgene Corporation - Product Pipeline Review - 2012" provides data on the Celgene Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Bial - Portela & Ca, S.A. - Product Pipeline Review - 2012" provides data on the Bial - Portela & Ca, S.A.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS). Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Other Gastrointestinal Disorders - Pipeline Review, H2 2012', provides an overview of the Other Gastrointestinal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Gastrointestinal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Gastrointestinal Disorders. 'Other Gastrointestinal Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD). 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Osteoarthritis - Pipeline Review, H2 2012', provides an overview of the Osteoarthritis therapeutic pipeline. This report provides information on the therapeutic development for Osteoarthritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Osteoarthritis. 'Osteoarthritis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Hemophilia - Pipeline Review, H2 2012', provides an overview of the Hemophilia therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hemophilia. 'Hemophilia - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Crohn's Disease - Pipeline Review, H2 2012', provides an overview of the Crohn's Disease therapeutic pipeline. This report provides information on the therapeutic development for Crohn's Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Crohn's Disease. 'Crohn's Disease - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

German consumers are in relatively confident mood in 2012 despite the recent global recession and current euro crisis. A strong job market and a positive outlook on their personal financial situation have encouraged Germans to spend freely. They expect the wider economy to deteriorate, however, due to the European debt crisis. But rather than wait for their euros to lose value in their bank accounts, consumers are keen to spend and invest on a wide range of products and services.

Cryogenic equipments are specially made equipments to handle liquefied gases. Liquefied gases are kept at very low temperature to maintain them in liquid state. The temperature required is below -150degC and known as cryogenic temperature. Due to the very low temperature these liquefied gases cannot be managed using normal equipments and thus require specially made equipments, known as cryogenic equipments. The mostly used cryogenic equipments are tanks, valves, vaporizers, and pumps.

Global Markets Direct's, 'Nosocomial Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Nosocomial Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nosocomial Infections. Nosocomial Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Inflammatory bowel diseases (IBDs) are mainly composed of three chronic diseases; Crohn's disease, ulcerative colitis, and indeterminate colitis. Although the etiology of inflammatory bowel disease is largely unknown, the incidence of IBD has substantially increased in the past decade.

In 2011, outbound tourists showed positive growth due to having longer leave entitlement, a stabilised Korean won against the US dollar and more diverse sales channels offering outbound travelling products at lower prices. Low-cost carriers' route expansion also contributed to the rise of outbound tourists, especially to Southeast Asia countries. In terms of inbound tourists, the March 2011 earthquake in Japan resulted in decreased traffic from that country, whilst Chinese arrivals showed...

BMI View: There have been mixed messages emanating from Chile's power market this quarter. While a series of new projects and proposals has been announced other less positive developments may worry investors. The already-delayed HidroAysen hydroelectric project was shaken further when Colbun's board suggested that the firm suspend the preparation of an environmental assessment study because of regulatory uncertainty. Chile's growing power requirements, particularly those of its energy-intensive mining sector, depend upon a reliable supply of electricity, so any delays to projects could deter potential investors and raise the likelihood that Chile will need to turn to expensive power imports.

Global Markets Direct's pharmaceuticals report, "Ipsen Inc. - Product Pipeline Review - 2012" provides data on the Ipsen Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The increasing prevalence of asthma and launch of new therapies will boost the Chinese asthma market (Tier 1 and Tier 2 cities) from $331m in 2012 to $489m by 2021. A number of novel products will increase the product offering on the market, however, with only a fraction of the patient pool market receiving asthma treatment, considerable untapped patient potential will remain.

Global Markets Direct's pharmaceuticals report, "Cyclacel Pharmaceuticals Inc. - Product Pipeline Review - 2012" provides data on the Cyclacel Pharmaceuticals Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The Computer Network Equipment Manufacturing industry in China comprises establishments that produce computer network equipment, including routers, switches, network safety equipment, WLAN equipment, fiber optic access equipment, ADSL equipment, hubs, modems and network cards.

Private equity firms manage investments in private companies. They may raise funds from external investors and invest on their behalf, or invest the firms’ own funds, or a combination of the two. Investments can include venture and growth capital for emerging companies as well as buyouts, including purchases of publicly traded companies to take them private. Firms earn revenue from management fees from outside investors, and profit or loss on investment of their own funds.

This industry comprises businesses that provide loans for home building or purchasing purposes, as well as taking deposits.

IP Multimedia Subsystem (IMS) represents a framework for development, deployment, and operation of various applications for support of any-network, any-device, and service provider usage. IMS consists of standards based technologies, architecture, and network elements that bring telephony type control to Internet based applications.

Value Retailers in Asia-Pacific: Market Guide to 2016 provides in-depth detail on the trends and drivers of the Value Retailers market in the Asia-Pacific. The report includes quantitative information (historic and forecast market values), segmented at channel level.

Home and Garden Products Retailing in Europe to 2016: Market Guide" provides in-depth detail on the trends and drivers of the Home and Garden Products Retailing market in the Europe. The report includes quantitative information (historic and forecast market values), segmented at category level.

Global Markets Direct's pharmaceuticals report, "OPKO Health, Inc. - Product Pipeline Review - 2012" provides data on the OPKO Health, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in China. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines, LNG terminals and underground gas storage facilities) in China. The report compares the investment environment in China with other countries in the region. The profiles of the major companies operating in the natural gas sector in China together with the latest news and deals are also included in the report.